RLTPR Antibody (EM-53) - BSA Free

Flow (Cell Surface): RLTPR Antibody (EM-53) [NBP2-62215] - Surface staining of RLTPR / CARMIL2 stable transfectants with anti-RLTPR / CARMIL2 (EM-53) PE.

Separation of RLTPR transfected cells stained using anti-human RLTPR (EM-53) purified antibody (GAM FITC, concentration in sample 9 ug/ml, red-filled) from RLTPR transfected cells stained using mouse IgG1 isotype control (MOPC-21) purified antibody (GAM FITC, concentration in sample 9 ug/ml, black-dashed) in Analysis (intracellular staining).

• Reactivity: Hu, Mu
• Applications: WB, Flow
• Clone: EM-53
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Format: BSA Free

RLTPR Antibody (EM-53) - BSA Free Summary

• Immunogen: Murine Rltpr (amino acids 1147-1397)
• Specificity: The mouse monoclonal antibody EM-53 recognizes RLTPR / CARMIL2, a protein playing a role in actin filament elongation.
• Isotype: IgG1 Kappa
• Clonality: Monoclonal
• Host: Mouse
• Gene: CARMIL2
• Purity: Protein A purified

Applications/Dilutions

• Dilutions:
  • Flow (Intracellular) 1-4 ug/ml
  • Flow Cytometry 1-4 ug/ml
  • Western Blot 1:100-1:2000

Packaging, Storage & Formulations

• Storage: Store at 4C. Do not freeze.
• Buffer: Phosphate buffered saline (PBS), pH 7.4
• Preservative: 15mM Sodium Azide
• Purity: Protein A purified

Alternate Names for RLTPR Antibody (EM-53) - BSA Free

• CARMIL2
• CARMIL2b
• leucine rich repeat containing 16C
• leucine-rich repeat-containing protein 16C
• LRRC16C
• RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing
• RGD, leucine-rich repeat, tropomodulin and proline-rich containing protein
• RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for RLTPR Antibody (NBP2-62215)(1)

Publication using NBP2-62215

• Zhu Y, Ye L, Huang H et Al. Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy Front Pediatr 2023-01-16 [PMID: 36727012]

Bioinformatics

• Gene Symbol: CARMIL2